CD­MO se­cures a $98M+ NIH con­tract for pro­duc­tion of pe­di­atric HIV-pre­ven­tion prod­ucts

Ad­vanced Bio­Science Lab­o­ra­to­ries, a CD­MO spe­cial­iz­ing in bio­ther­a­pies, vi­ral vec­tor-based vac­cines and on­colyt­ics, has re­ceived a de­vel­op­ment and man­u­fac­tur­ing con­tract from the US gov­ern­ment. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.